Identification, Synthesis, and Characterization of N-Formyl Mirabegron: A New Degradation Product Formed by Formic Acid Impurity in Pharmaceutical Excipients
2024

New Degradation Product of Mirabegron from Formic Acid Impurity

Sample size: 6 publication 10 minutes Evidence: moderate

Author Information

Author(s): Bashir Daoud Agha Dit Daoudy, Mohammad Ammar Al-Khayat, Ghassan Abo Chameh, Mohammad Amer Al Mardini

Primary Institution: Damascus University

Hypothesis

The study aims to demonstrate the role of formic acid impurity in mirabegron-excipient incompatibility and to identify, synthesize, and characterize a new degradation product.

Conclusion

The study confirmed that formic acid impurity leads to the formation of a new degradation product, N-formyl mirabegron, during compatibility testing with certain excipients.

Supporting Evidence

  • The study identified a new degradation product, FAc-DP, formed from mirabegron and formic acid.
  • Compatibility tests showed that FAc-DP was present at 0.2% after 7 days of incubation.
  • The structure of FAc-DP was confirmed using LC-MS and NMR techniques.

Takeaway

When making medicine, sometimes bad stuff can sneak in and change it. This study found that a common impurity can make a new version of a medicine called mirabegron.

Methodology

The study involved compatibility tests between mirabegron and excipients, followed by synthesis and characterization of the degradation product using HPLC and NMR.

Limitations

The study may not account for all possible interactions with other excipients or impurities not tested.

Digital Object Identifier (DOI)

10.1155/adpp/4971456

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication